Barkai, Laszlo J.
Gonczi, Lorant
Balogh, Fruzsina
Angyal, Dorottya
Farkas, Klaudia
Farkas, Bernadett
Molnar, Tamas
Szamosi, Tamas
Schafer, Eszter
Golovics, Petra A.
Juhasz, Mark
Patai, Arpad
Vincze, Aron
Sarlos, Patricia
Farkas, Alexandra
Dubravcsik, Zsolt
Toth, Tamas G.
Szekely, Hajnal
Miheller, Pal
Lakatos, Peter L.
Ilias, Akos
Funding for this research was provided by:
Semmelweis University
Article History
Received: 12 February 2024
Accepted: 26 June 2024
First Online: 28 June 2024
Competing interests
: LJB, LG, FB, DA, BF, TS, ES, PAG, MJ, AP, AV, PS, AF, ZD, TGT, HSz, PM, PLL, and AI declare no conflict of interest. Klaudia Farkas has received speaker’s honoraria from AbbVie, Janssen, Ferring, Takeda, Pfizer, Bristol-Myers Squibb and Goodwill Pharma. Tamás Molnár has received speaker’s honoraria from MSD, AbbVie, Egis, Goodwill Pharma, Takeda, Pfizer, Janssen, Sandoz, MundiPharma, Phytotec, Roche, Fresenius, Bristol-Myers Squibb, Lilly and Teva.